The non-transformed cell line MCF10A was far less sensitive to Oridonin, with IC50 value 100 times higher than that in breast cancer cells with AKT activation (Supplementary Figure 3), leading to potent and selective cytotoxicity while sparing normal cells. The gene discussed is AKT1; the disease is breast cancer.